56
Participants
Start Date
July 28, 2017
Primary Completion Date
January 9, 2020
Study Completion Date
July 9, 2020
AMPLEX
A bone graft substitute
Autogenous Bone Graft (ABG)
Control material administered by surgical implant
University of Rochester School of Medicine, Rochester
University Orthopedics Center, State College
Pennsylvania Hospital, Philadelphia
Reconstructive Orthopaedic Associates, Philadelphia
Sinai Hospital of Baltimore, Inc / Rubin Institute for Advanced Orthopedics, Baltimore
Medstar, Baltimore
University of Virginia Health System, Charlottesville
University of North Carolina at Chapel Hill, Chapel Hill
OrthoCarolina Research Institute, Inc., Charlotte
Emory Orthopaedic and Spine Hospital, Atlanta
Andrews Orthopaedic and Sports Medicine Center, Gulf Breeze
Campbell Clinic Orthopaedics, Germantown
Michigan Orthopedic Center, Lansing
Orthopaedic Associates of Michigan, Research and Education Institute, Grand Rapids
TRIA Orthopaedic Center, Bloomington
Loyola University Medical Center, Maywood
Midwest Orthopedics at Rush, Chicago
Baylor St. Luke's Medical Center, Houston
Texas Tech University Health Sciences Center, Lubbock
University of Colorado School of Medicine, Aurora
Arizona Research Center, Phoenix
Physician Research Group, Gilbert
Desert Orthopaedic Center, Las Vegas
California Pacific Orthopaedics, San Francisco
Hartford Hospital, Hartford
Dartmouth Hitchcock Medical Center, Lebanon
Rutgers, Newark
University of Texas Medical Branch, Galveston
University of Alberta System, Edmonton
Central Alberta Orthopedics, Red Deer
St. Paul's Hospital, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
Ottawa Hospital Research Institute, Ottawa
St. Michael's Hospital, Toronto
Jewish General Hospital, Montreal
University of Laval, Québec
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY